Citadel Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $607M | Buy |
|
|||||
2025
Q1 | $602M | Buy |
|
|||||
2024
Q4 | $434M | Sell |
|
|||||
2024
Q3 | $421M | Buy |
|
|||||
2024
Q2 | $19.1M | Sell |
|
|||||
2024
Q1 | $390M | Buy |
|
|||||
2023
Q4 | $32.5M | Buy |
|
|||||
2023
Q3 | $29.4M | Buy |
|
|||||
2023
Q2 | $23M | Sell |
|
|||||
2023
Q1 | $187M | Buy |
|
|||||
2022
Q4 | $142M | Buy |
|
|||||
2022
Q3 | $21.1M | Sell |
|
|||||
2022
Q2 | $193M | Buy |
|
|||||
2022
Q1 | $146M | Buy |
|
|||||
2021
Q4 | $48.2M | Buy |
|
|||||
2021
Q3 | $27.7M | Sell |
|
|||||
2021
Q2 | $79.6M | Sell |
|
|||||
2021
Q1 | $396M | Buy |
|
|||||
2020
Q4 | $233M | Buy |
|
|||||
2020
Q3 | $180M | Buy |
|
|||||
2020
Q2 | $140M | Buy |
|
|||||
2020
Q1 | $42M | Sell |
|
|||||
2019
Q4 | $88.2M | Sell |
|
|||||
2019
Q3 | $127M | Sell |
|
|||||
2019
Q2 | $184M | Sell |
|
|||||
2019
Q1 | $370M | Buy |
|
|||||
2018
Q4 | $202M | Sell |
|
|||||
2018
Q3 | $262M | Buy |
|
|||||
2018
Q2 | $209M | Sell |
|
|||||
2018
Q1 | $303M | Buy |
|
|||||
2017
Q4 | $158M | Buy |
|
|||||
2017
Q3 | $3.99M | Sell |
|
|||||
2017
Q2 | $161M | Buy |
|
|||||
2017
Q1 | $9.57M | Sell |
|
|||||
2016
Q4 | $29.1M | Buy |
|
|||||
2016
Q3 | $3.52M | Sell |
|
|||||
2016
Q2 | $4.51M | Sell |
|
|||||
2016
Q1 | $63.1M | Buy |
|
|||||
2015
Q4 | $65.9M | Sell |
|
|||||
2015
Q3 | $143M | Buy |
|
|||||
2015
Q2 | $47M | Sell |
|
|||||
2015
Q1 | $113M | Buy |
|
|||||
2014
Q4 | $103M | Buy |
|
|||||
2014
Q3 | $25.9M | Sell |
|
|||||
2014
Q2 | $20.9M | Sell |
|
|||||
2014
Q1 | $61.3M | Sell |
|
|||||
2013
Q4 | $98.9M | Buy |
|
|||||
2013
Q3 | $45.1M | Sell |
|
|||||
2013
Q2 | $38.1M | Buy |
|